Marshall Edwards, Inc.
(NASDAQ:MSHL)|
0.800 0.000 (0.00%) Jan 08 - Close |
|
|
|
Pre-Market 1.49 +0.69 (86.25%) Fri, 9 Jan 2009 8:40 AM
- Compare MSHL with:
- View: Line | Candlestick
Company Profile
Marshall Edwards, Inc.
140 Wicks Road
North Ryde NSW, 2113
Australia - Map
Phone: 01161288776196
Fax: 01161298788474
Website: www.marshalledwardsinc.com
State of incorporation: Delaware
CEO: Christopher Naughton
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev and commercialize cancer treatment drugs
A developmental stage pharmaceutical company formed for the purpose of development and commercialization of drugs for the treatment of cancer.
Recent news for MSHL
-
Marshall Edwards, Inc. Granted IND for Triphendiol
Marketwire - Jan 07 at 8:10 ET
-
EDGAR Online - Dec 19 2008 at 8:36 ET
-
Marketwire - Dec 19 2008 at 8:15 ET
-
Marshall Edwards, Inc. Files IND Application for Triphendiol
Marketwire - Dec 01 2008 at 8:10 ET
-
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
Marketwire - Nov 13 2008 at 8:10 ET
-
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
Marketwire - Nov 12 2008 at 8:10 ET
-
MARSHALL EDWARDS INC Financials
EDGAR Online Financials - Nov 11 2008 at 9:04 ET
-
MARSHALL EDWARDS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 06 2008 at 6:02 ET
-
Marketwire - Oct 30 2008 at 6:18 ET
-
EDGAR Online - Oct 14 2008 at 8:13 ET